Tone mix
Week by week 47 weeks
Share of Disc Medicine, Inc. Common Stock's 180 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Dec 22, 2025 · tone -100Disc Medicine (NASDAQ:IRON) Shares Down 9% After Insider Selling-135
- Week of Mar 23, 2026 · tone +99Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria+103
- Week of Mar 2, 2026 · tone -99Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection-97
- Week of Sep 7, 2026 · tone +100Disc Medicine's (IRON) Outperform Rating Reiterated at Wedbush+92
- Week of Nov 3, 2025 · tone 0Disc Medicine to Participate in Upcoming Investor Conferences-69
- Week of Dec 1, 2025 · tone 0Sio Capital Management LLC Raises Holdings in Disc Medicine, Inc. $IRON-69
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Disc Medicine, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 5 | +38 |
| Last 30 sessions | 19 | +41 |
| Last 90 sessions | 67 | +17 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, October 22, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletDisc Medicine (NASDAQ:IRON) Director Kevin Bitterman Sells 5,312 Shares of Company StockNeutral
- www.themarketsdaily.com · 1 outletDisc Medicine (NASDAQ:IRON) Director Sells 10,994 Shares of StockNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Disc Medicine (NASDAQ:IRON) Director Kevin Bitterman Sells 5,312 Shares of Company Stock | www.dailypolitical.com | 1 | Neutral |
| Disc Medicine (NASDAQ:IRON) Director Sells 10,994 Shares of Stock | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 21, 2026
3 headlines, average tone +63: 2 positive, 1 neutral and 0 negative. Showing all 3.
- www.themarketsdaily.com · 1 outletDisc Medicine, Inc. (NASDAQ:IRON) Stock Has Average Price Target of $110.18Positive
- www.manilatimes.net · 1 outletDisc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common StockPositive
- www.finanzen.ch · 1 outletDisc Medicine Prices $450 Mln Offering Of Shares At $75/shr To Fund Pipeline DevelopmentNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Disc Medicine, Inc. (NASDAQ:IRON) Stock Has Average Price Target of $110.18 | www.themarketsdaily.com | 1 | Positive |
| Disc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock | www.manilatimes.net | 1 | Positive |
| Disc Medicine Prices $450 Mln Offering Of Shares At $75/shr To Fund Pipeline Development | www.finanzen.ch | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 20, 2026
7 headlines, average tone +71: 5 positive, 2 neutral and 0 negative. Showing all 7.
- www.ibtimes.com.au · 1 outletDisc Medicine Stock Soars 31% After Bitopertin Hits All Goals in Pivotal Trial for Rare Sunlight DisorderPositive
- www.proactiveinvestors.com · 1 outletDisc Medicine surges 38% after bitopertin clears Phase 3 trial endpointsPositive
- www.rttnews.com · 1 outletDisc Medicine's Bitopertin Meets All Phase 3 Goals; FDA Resubmission PlannedPositive
- www.rttnews.com · 1 outletDisc Medicine Launches $350M Stock Offering Following Positive Phase 3 ResultsPositive
- www.rttnews.com · 1 outletBiotech Stocks Rally: SLN Soars 125%, WORX Jumps 105%, IRON Gains 41%Positive
- www.manilatimes.net · 1 outletDisc Medicine Announces Proposed $350 Million Public Offering of Common Stock and Pre-Funded WarrantsNeutral
- www.dailypolitical.com · 1 outletStock Traders Purchase High Volume of Disc Medicine Put Options (NASDAQ:IRON)Neutral
Show the table · 7 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Disc Medicine Stock Soars 31% After Bitopertin Hits All Goals in Pivotal Trial for Rare Sunlight Disorder | www.ibtimes.com.au | 1 | Positive |
| Disc Medicine surges 38% after bitopertin clears Phase 3 trial endpoints | www.proactiveinvestors.com | 1 | Positive |
| Disc Medicine's Bitopertin Meets All Phase 3 Goals; FDA Resubmission Planned | www.rttnews.com | 1 | Positive |
| Disc Medicine Launches $350M Stock Offering Following Positive Phase 3 Results | www.rttnews.com | 1 | Positive |
| Biotech Stocks Rally: SLN Soars 125%, WORX Jumps 105%, IRON Gains 41% | www.rttnews.com | 1 | Positive |
| Disc Medicine Announces Proposed $350 Million Public Offering of Common Stock and Pre-Funded Warrants | www.manilatimes.net | 1 | Neutral |
| Stock Traders Purchase High Volume of Disc Medicine Put Options (NASDAQ:IRON) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
4 headlines, average tone +25: 2 positive, 1 neutral and 1 negative. Showing all 4.
- www.dailypolitical.com · 1 outletDisc Medicine (NASDAQ:IRON) Stock Gets Downgrade from Wall Street ZenNegative
- seekingalpha.com · 1 outletDisc Medicine posts late-stage trial win for Roche drug (IRON)Positive
- www.rttnews.com · 1 outletDisc Medicine Set To Report Phase 3 Bitopertin Results In Rare Blood Disorder; Stock UpPositive
- www.manilatimes.net · 1 outletDisc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)Neutral
Show the table · 4 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Disc Medicine (NASDAQ:IRON) Stock Gets Downgrade from Wall Street Zen | www.dailypolitical.com | 1 | Negative |
| Disc Medicine posts late-stage trial win for Roche drug (IRON) | seekingalpha.com | 1 | Positive |
| Disc Medicine Set To Report Phase 3 Bitopertin Results In Rare Blood Disorder; Stock Up | www.rttnews.com | 1 | Positive |
| Disc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP) | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 5, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.prnewswire.com · 2 outletsRosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation | www.prnewswire.com | 2 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Disc Medicine, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.